Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

  • Indian J Med Res. 2023 Jan;157(1):100-103. doi: 10.4103/ijmr.ijmr_233_22.
Praisy K Prabha  1 ,  Ajay Prakash  2 ,  Bikash Medhi  2
Affiliations
  • 1. Department of Neurology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India.
  • 2. Department of Pharmacology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India.
PMID: 37040235 DOI: 10.4103/ijmr.ijmr_233_22
Products